Economies.com provides the latest technical analysis and forecast of the american stocks, in order to keep track of the trend of the US stocks.
Pfizer's stock rose after leaning on the support of 42.52, while also leaning on the upside short-term trend line, scoring a profit of 0.70%, or 0.30 points, while curbed by negative pressure from the 50-day SMA, in addition to negative signals from the RSI.
Therefore we expect more gains for the stock, as long as the support of 42.52 holds on, targeting the first resistance of 44.61.
Expected trend for today: Bullish